Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - TOTAL EQUITY
Total Equity ADAP - Adaptimmune Therapeutics plc
39.5 M
LAST VALUE
-56.20%
2 YEAR CAGR
-30.68%
5 YEAR CAGR
35.15%
10 YEAR CAGR